Biocorrx Inc. (OTCMKTS:BICX) Sees Significant Growth in Short Interest

by · The Cerbat Gem

Biocorrx Inc. (OTCMKTS:BICX – Get Free Report) saw a large increase in short interest during the month of August. As of August 31st, there was short interest totaling 18,093 shares, an increase of ∞ from the August 15th total of 0 shares. Approximately 0.1% of the shares of the stock are sold short. Based on an average trading volume of 8,509 shares, the short-interest ratio is presently 2.1 days.

Biocorrx Price Performance

Shares of BICX stock opened at $0.25 on Thursday. The company’s fifty day simple moving average is $0.26 and its two-hundred day simple moving average is $0.33. Biocorrx has a 52 week low of $0.15 and a 52 week high of $1.28. The stock has a market cap of $7.55 million, a P/E ratio of -2.08 and a beta of 0.19.

Biocorrx (OTCMKTS:BICX – Get Free Report) last issued its quarterly earnings data on Friday, August 14th. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02. The firm had revenue of $0.09 million for the quarter, compared to analysts’ expectations of $0.24 million.

Biocorrx Company Profile

(Get Free Report)

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.

See Also